Tethys’ share of the production, before government take, from Blocks 3 and 4 onshore the Sultanate of Oman amounted in September 2013 to 141,394 barrels of oil, corresponding to 4,713 barrels of oil per day (bopd). The total production from Blocks 3 and 4 amounted in September to 471,312 barrels of oil, corresponding to 15,710 bopd. The production includes production from the Farha South field on Block 3, the Saiwan East field on Block 4 and test production from the B4EW4 discovery on Block 4. Tethys Oil AB, through its wholly owned subsidiary Tethys Oil Block 3 and 4 Ltd, has a 30 per cent interest in Blocks 3 and 4. Partners are Mitsui E&P Middle East B.V. with 20 per cent and the operator CC Energy Development S.A.L. (Oman branch) holding the remaining 50 per cent. For further information, please contact Magnus Nordin, Managing Director, phone +46 70 576 6555; magnus@tethysoil.com -------------------------------------------------------------------------------- --------------------------------- Tethys Oil AB (publ) Tethys Oil is a Swedish energy company focused on exploration and production of oil and natural gas. Tethys Oil’s core area is Oman, where the company is one of the largest onshore oil and gas concession holders. Tethys Oil also has exploration and production assets onshore France, Lithuania and Sweden. The shares are listed on NASDAQ OMX Stockholm (TETY) in Stockholm. Website: www.tethysoil.com
Production update September 2013 Tethys’ share of the
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
FDA Greenlights Kisqali®: A Major Step for Breast Cancer Care
Kisqali® Receives FDA Approval for Early Breast Cancer Treatment Novartis has some exciting news for oncology: the US Food and Drug Administration (FDA) has officially approved Kisqali® (ribociclib) as a treatment for patients diagnosed with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer...
Continue Reading
Ålandsbanken Abp Launches SEK 350M Additional Tier 1 Notes Series
Ålandsbanken Abp Issues SEK 350,000,000 Additional Tier 1 Notes Ålandsbanken Abp, a prominent player in the banking industry, recently made waves in the financial market by issuing Additional Tier 1 floating rate notes amounting to SEK 350,000,000. The issuance marks a significant step in Ålandsbanken's strategic move to strengthen its capital position and enhance its...
Continue Reading
Harbour BioMed's 2025 Achievements and Future Prospects
Harbour BioMed Achieves Significant Milestones in Interim Results Harbour BioMed (HKEX: 02142) is a prominent biopharmaceutical company focused on developing innovative antibody therapeutics, particularly in the fields of immunology and oncology. The company shared its impressive interim results for the first half of the year, showcasing remarkable growth and strategic...
Continue Reading
Innovative Investment Fuels Okika Devices' Future Growth Strategy
Strategic Investment Boosts Okika Devices Advancement Colorado ONE Fund, which is part of the ONE Funds initiative, has made a major investment in Okika Devices, a company recognized for its innovation in Field Programmable Analog Array (FPAA) technology. This investment aligns with Colorado ONE Fund's mission to support technologies that advance the local innovation...
Continue Reading
Investors Take Note: Legal Options for Shareholders Explored
Exploring Legal Options for Investors in Major Companies In recent developments, Halper Sadeh LLC, a reputable law firm focusing on investor rights, is carefully examining three significant companies for potential violations of federal securities laws. This investigation centers around the actions and decisions made by these firms, which may affect shareholders' rights...
Continue Reading